Establishing a classification of the stages of progression of the novel coronavirus infection to improve and facilitate morphologic diagnosis

Yevgeniy Sokharev, Aliya Bugubaeva, Kuanysh Zhumalynov, Elizaveta Koneva, Liudmila Babaskina, Jamilya Nugmanova, Khizir Bataev, Shemia Chupanova, Yerbol Isakaev, Murat Nurushev, Vadim Chashkov, Gulnaz Yermoldina, Andrey Baksheev

Abstract


Background: COVID-19, caused by SARS-CoV-2, has impacted over 264 million people and caused over 5 million deaths worldwide. Symptoms often include viral pneumonia, with complications like acute respiratory distress or sepsis, as well as myocarditis and kidney damage. The purpose of the study is to investigate the impact of COVID-19 on endocrine glands, as well as to develop a classification of stages of the course of COVID-19 to improve and simplify morphological diagnosis.

Methods: The studies conducted include systemic analysis of the para-clinical data of patients who died of COVID-19 (according to medical documentation); a macroscopic study assessing the size and weight of external manifestations of endocrine organ lesions in COVID-19 cases with statistical evaluation of the detected signs. Archive analysis covers para-clinical data and data on significant concomitant and background pathologies based on the medical histories of 780 deaths from COVID-19 in infectious diseases hospitals of the city of Kostanay (Kazakhstan) during the period from 2019 to 2022.

Result: Using pathomorphologic data from COVID-19 autopsies, we developed a scale for semi-quantitative analysis of each case. Medical data analysis suggests that the most notable endocrine changes are elevated blood glucose and low catecholamine levels due to adrenal hemosiderosis. No significant changes in sex or thyroid hormones were observed.

Conclusion: The obtained findings require further consideration, given that the studied patients make up a rather diverse group. Nevertheless, the study can serve as an additional source of information in the struggle against COVID-19.

Keywords: Coronavirus infection; Endocrine glands; Stage of disease 


Full Text:

PDF

References


Khurshid A, Amin R, Aziz A, Ahmed O, Abdel-Haliem MEF. Decipher the potential therapeutic intervention points of 2019-nCoV: a pharmacological perspective. Advancements in Life Sciences, (2022); 9(4): 412-429.

Shlyakhto EV, Konradi AO, Arutyunov GP, Arutyunov AG, Bautin AE, Boytsov SA et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology, (2020); 25(3): 1-21.

Ye M, Wysocki J, William J, Soler MJ, Cokic I, Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. Journal of the American Society of Nephrology, (2006); 17(11): 3067-3075.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, (2020); 395(10223): 497-506.

Islamova YK, Bataev KM. Epidemiological aspects and prevention of coronavirus infection (COVID-19). Bulletin of the Medical Institute, (2023); 1(22): 42-46.

Soldevila B, Puig-Domingo M, Marazuela M. Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated? Reviews in Endocrine and Metabolic Disorders, (2021); 23: 137-150.

Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. Journal of Virology, (2020); 94(7).

Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious Diseases of Poverty, (2020); 9(1): 45.

Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine, (2005); 11(8): 875-879.

Liu F, Long X, Zou W, Fang M, Wu W, Li W et al. Highly ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection. medRxiv, (2020).

Morse JS, Lalonde T, Xu S, Liu WR. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem, (2020); 21(5): 730-738.

Rehman S, Nnabuike UE, Abbas A, Rahman A, Malik U, Effendi MH, Hussain K, Raza MA. A study on the Impacts of COVID-19 on health, Economy, Employment and Social Life of People in Indonesia. Advancements in Life Sciences, (2022); 9(3): 340-6.

Mao Y, Xu B, Guan W, Xu D, Li F, Ren R et al. The adrenal cortex, an underestimated site of SARS-CoV-2 infection. Frontiers in Endocrinology, (2021); 11: 593179.

Müller JA, Groß R, Conzelmann C, Krüger J, Merle U, Steinhart J et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nature Metabolism, (2021); 3: 149-165.

Wu CT, Lidsky PV, Xiao Y, Lee IT, Cheng R, Nakayama T et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metabolism, (2021); 33: 1565-1576.

Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clinical Endocrinology. (2005); 63(2): 197-202.

Ma L, Xie W, Li D, Shi L, Ye G, Mao Y et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. Journal of Medical Virology, (2021); 93(1): 456-462.

Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system–a mini-review. Endocrinology, (2021); 163(1): bqab203.

Wang W, Su X, Ding Y, Fan W, Zhou W, Su J et al. Thyroid function abnormalities in COVID-19 patients. Frontiers in Endocrinology, (2021); 19(11): 623792.

Ghazanfar H, Kandhi S, Shin D, Muthumanickam A, Gurjar H, Qureshi Za et al. Impact of COVID-19 on the gastrointestinal tract: a clinical review. Cureus, (2022); 14(3): e23333.




DOI: http://dx.doi.org/10.62940/als.v11i4.3447

Refbacks

  • There are currently no refbacks.